
Technical analysis of Krystal Biotech, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis bullosa and develops multiple therapeutic candidates in various clinical stages for ophthalmological, dermatological, and other disease conditions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the KRYS analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is Krystal Biotech, Inc. analysed technically?
Technical analysis of Krystal Biotech, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Krystal Biotech, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Krystal Biotech, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Krystal Biotech, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.